The Optimal "Time in Range" and "Time below Range" are Difficult to Coordinate in Patients with Type 1 Diabetes

被引:4
|
作者
Sekiguchi, Sho [1 ]
Yamada, Eijiro [1 ]
Nakajima, Yasuyo [1 ]
Matsumoto, Shunichi [1 ]
Yoshino, Satoshi [1 ]
Horiguchi, Kazuhiko [1 ]
Ishida, Emi [1 ]
Uehara, Ryota [1 ]
Okada, Shuichi [1 ]
Yamada, Masanobu [1 ]
机构
[1] Gunma Univ, Dept Med & Mol Sci, Grad Sch Med, 3-39-15 Showa Machi, Maebashi, Gunma 3718511, Japan
来源
关键词
continuous glucose monitoring; diabetes mellitus; time above range; time below range; time in range;
D O I
10.1620/tjem.255.221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Achieving the optimal glucose level time in range (TIR), as recently proposed by the "International Consensus on Time in Range," is challenging. We retrospectively analyzed data from 192 patients, including 58 with type 1 diabetes, using the FreeStyle Libre Pro system. This device was used by physicians for continuous glucose monitoring (CGM) and for making therapeutic decisions based on unbiased data, as the patients were blinded to their blood glucose levels during monitoring. The desired 70% TIR among patients with type 2 diabetes corresponded to an HbA1c of 7.7%. Importantly, however, a 70% TIR for patients with type 1 diabetes corresponded to an HbA1c of 6.9%, which diverged markedly from the HbA1c of 7.9% that corresponded to the desired 4% time below range (TBR). Moreover, these dissociations were observed more in patients with type 1 diabetes with a higher % coefficient of variation (> 36%). Hence, while the TIR is strongly correlated with HbA1c, it is difficult to coordinate with the TBR in Japanese patients with type 1 diabetes. As these metrics (which are critical indicators in clinical practice) are rapidly gaining popularity globally, including in Japan, our data strongly support the cautious use of new CGM metrics such as TIR and TBR/time above range, and emphasize the importance of individualized treatment in achieving the optimal TIR and TBR, especially in patients with type 1 diabetes.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 50 条
  • [1] CGM Time Below Range Predicts Epinephrine Response to Hypoglycemia in Patients with Type 1 Diabetes
    Thomas, Robert L.
    Gregory, Justin M.
    Giovannetti, Erin R.
    Boeder, Schafer C.
    Pettus, Jeremy
    DIABETES, 2023, 72
  • [2] Time in Range and Time Below Range in Insulin-Treated Older Adults with Type 2 Diabetes
    Leite, Silmara A. O.
    Silva, Michael
    Lavalle, Ana C. R.
    Bastos, Murilo
    Bertogy, Maria C.
    Vieira, Suelen C.
    Umpierrez, Guillermo E.
    DIABETES, 2022, 71
  • [3] Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes
    Zhou-qin Feng
    Qing-yu Guo
    Wei Wang
    Yan-yu Yuan
    Xu-guang Jin
    Hui Zhou
    Jun Liu
    Hai-yan Lei
    Xin-yi Yang
    Jun Liu
    Bin Lu
    Jia-qing Shao
    Ping Gu
    Diabetology & Metabolic Syndrome, 13
  • [4] Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes
    Feng, Zhou-qin
    Guo, Qing-yu
    Wang, Wei
    Yuan, Yan-yu
    Jin, Xu-guang
    Zhou, Hui
    Liu, Jun
    Lei, Hai-yan
    Yang, Xin-yi
    Liu, Jun
    Lu, Bin
    Shao, Jia-qing
    Gu, Ping
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [6] Time above range and not time below range is associated with mortality in older patients with type 2 diabetes: results from the HYPOAGE study
    Smati, S.
    Boureau, A. -S.
    Guyomarch, B.
    Allix, I.
    Annweiler, C.
    Cervantes, N.
    Delabriere, I.
    Gourdy, P.
    Guyonnet, S.
    Litke, R.
    Paccalin, M.
    Penfornis, A.
    Saulnier, P. -J.
    Hadjadj, S.
    Cariou, B.
    DIABETOLOGIA, 2024, 67 : S103 - S104
  • [7] Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon?
    Hamidi, Vala
    Pettus, Jeremy H.
    DIABETES CARE, 2024, 47 (05) : 782 - 784
  • [8] Variation of glucose time in range in type 1 diabetes
    Hansen, Klavs Wurgler
    Bibby, Bo Martin
    ENDOCRINOLOGY DIABETES & METABOLISM, 2022, 5 (06)
  • [9] Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes
    Thomas, Robert L.
    Boeder, Schafer C.
    Hamidi, Vala
    Giovannetti, Erin R.
    Gregory, Justin M.
    Pettus, Jeremy H.
    DIABETES CARE, 2024, 47 (05) : e39 - e41
  • [10] THE ADDITION OF EMPAGLIFLOZIN INCREASES TIME IN RANGE IN TYPE 1 DIABETES MELLITUS PATIENTS
    Lunder, M.
    Janic, M.
    Janez, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A186 - A186